F
Faeth Therapeutics, Inc.
FTH · NASDAQ · Healthcare · 834M
Closing price
$26.03
+1.64% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
1.8×
Enterprise value / EBITDAEV/EBITDA
-1.2×
Free cash flow yieldFCF yield
-62.4%
Return on equityROE
-113.4%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
0.3×
Interest coverage
-696.5×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.